|Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells*♦|
K Suzuki-Inoue, Y Kato, O Inoue, MK Kaneko, K Mishima, Y Yatomi, ...
Journal of Biological Chemistry 282 (36), 25993-26001, 2007
|Molecular identification of Aggrus/T1α as a platelet aggregation-inducing factor expressed in colorectal tumors|
Y Kato, N Fujita, A Kunita, S Sato, M Kaneko, M Osawa, T Tsuruo
Journal of Biological Chemistry 278 (51), 51599-51605, 2003
|Molecular analysis of the pathophysiological binding of the platelet aggregation‐inducing factor podoplanin to the C‐type lectin‐like receptor CLEC‐2|
Y Kato, MK Kaneko, A Kunita, H Ito, A Kameyama, S Ogasawara, ...
Cancer science 99 (1), 54-61, 2008
|Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression|
K Mishima, Y Kato, MK Kaneko, R Nishikawa, T Hirose, M Matsutani
Acta neuropathologica 111, 483-488, 2006
|Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain|
Y Kato, MK Kaneko, A Kuno, N Uchiyama, K Amano, Y Chiba, ...
Biochemical and biophysical research communications 349 (4), 1301-1307, 2006
|Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma|
Y Kato, M Kaneko, M Sata, N Fujita, T Tsuruo, M Osawa
Tumor Biology 26 (4), 195-200, 2005
|The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis|
A Kunita, TG Kashima, Y Morishita, M Fukayama, Y Kato, T Tsuruo, ...
The American journal of pathology 170 (4), 1337-1347, 2007
|Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys|
Y Kato, E Arakawa, S Kinoshita, A Shirai, A Furuya, K Yamano, ...
Biochemical and biophysical research communications 267 (2), 597-602, 2000
|PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin|
Y Fujii, M Kaneko, M Neyazaki, T Nogi, Y Kato, J Takagi
Protein expression and purification 95, 240-247, 2014
|The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model|
H Liu, Y Kato, SA Erzinger, GM Kiriakova, Y Qian, D Palmieri, PS Steeg, ...
BMC cancer 12, 1-11, 2012
|A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin|
Y Kato, MK Kaneko
Scientific reports 4 (1), 5924, 2014
|Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors|
Y Kato, I Sasagawa, M Kaneko, M Osawa, N Fujita, T Tsuruo
Oncogene 23 (52), 8552-8556, 2004
|Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor|
MK Kaneko, Y Kato, T Kitano, M Osawa
Gene 378, 52-57, 2006
|Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma|
K Mishima, Y Kato, MK Kaneko, Y Nakazawa, A Kunita, N Fujita, T Tsuruo, ...
Acta neuropathologica 111, 563-568, 2006
|Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification|
A Kuno, Y Kato, A Matsuda, MK Kaneko, H Ito, K Amano, Y Chiba, ...
Molecular & Cellular Proteomics 8 (1), 99-108, 2009
|A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation|
Y Kato, G Jin, CT Kuan, RE McLendon, H Yan, DD Bigner
Biochemical and biophysical research communications 390 (3), 547-551, 2009
|A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma|
N Maekawa, S Konnai, S Takagi, Y Kagawa, T Okagawa, A Nishimori, ...
Scientific reports 7 (1), 8951, 2017
|Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing|
S Takano, W Tian, M Matsuda, T Yamamoto, E Ishikawa, MK Kaneko, ...
Brain tumor pathology 28, 115-123, 2011
|Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor|
MK Kaneko, Y Kato, A Kameyama, H Ito, A Kuno, J Hirabayashi, T Kubota, ...
FEBS letters 581 (2), 331-336, 2007
|Deletion polymorphism of SIGLEC14 and its functional implications|
M Yamanaka, Y Kato, T Angata, H Narimatsu
Glycobiology 19 (8), 841-846, 2009